Systemic anti-inflammation by synthetic interleukin-1 blockers

Acta Pharmacologica Sinica

Volumn 20, Issue 5, 1999, Pages 405-408

  Chiou, George C Y ^a   Liu, Shirley X L ^b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b Nanjing Welman Institute of Materia Medica   (China)

Author keywords

Aspirin; Carrageenan; Inflammation; Nonsteroidal anti inflammatory agents; OB 101; OB 186; Ophthalmic solutions

Indexed keywords

3,4 DIMETHYL 9(10H) ACRIDONE; 5 BROMOTETRAHYDRO 5 METHYL 3 PHENYL 2 PHENYLIMINO 4H 1,3 THIAZINE; ACETYLSALICYLIC ACID; CARRAGEENAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; OB 101; OB 186; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; EYE IRRITATION; FEMALE; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LD 50; MALE; NONHUMAN; RABBIT; RAT; RHEUMATOID ARTHRITIS;

ACRIDINES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; IMINES; INFLAMMATION; INTERLEUKIN-1; LETHAL DOSE 50; MALE; MICE; RABBITS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THIAZINES;

EID: 0033008365     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chiou GCY, Chang MS. Ocular inflammation induced by lens protein and its prevention with new agents. In; Bazan NG, editor. New trends in lipid mediator research, lipid mediators in eye inflammation. Basel: Karger; 1990. p 9-1-109.
2. Masuda K. Anti-inflammatory agents; non-steroidal antiinflammatory drugs. In: Sears ML, editor. Pharmacology of the eye. New York : Springer-Verlag ; 1984. p 539-51.
3. Braquet P. Handbook of PAF and PAT antagonists. Boca Raton: CRC Press; 1991. p 97-258.
4. Melli M, Parente L. Cytokines and lipocortins in inflammation and differentiation. New York : Wiley-Liss; 1990. p 183-91.
5. Dawson MM. Lymphokines and interleukins. Boca Raton; CRC Press; 1991. p 82-105.
6. Chiou GCY, Liu SXL. Novel non-arachidonate mediated, non-steroidal anti-inflammatory agents. Expert Opinion Inv Drugs 1994; 3: 725-32.
7. Chiou GCY, Yao QS, Chang MS, Okawara T. Prevention and treatment of ocular inflammation with a new class of non-steroidal anti-inflammatory agent. J Ocular Pharmacol 1994; 10: 335-47.
8. Chiou GCY, Yao QS, Okawara T. Prevention of ocular inflammation induced by lens protein, endotoxin and interleukin-1 with synthetic IL-1 blockers. J Ocular Pharmacol 1994; 10: 577-86.
9. Chiou GCY, Chen JZ, Xuan B, Yamasaki T, Okawara T. Antagonism of interleukin-l (IL-1) induced uveitis with synthetic IL-1 blockers. J Ocular Pharmacol Ther 1997; 13: 427-33.
10. Xuan B, Chiou GCY, Yamasaki T, Okawara T. Antiuveitis and inhibition of fibroblast-like corneal and conjunctival all cultures by interleukin-1 blockers, CK 125, CK 126 and CK 128. Ophthalmic Res 1998; 30: 180-8.
11. Chiou GCY, Xuan B, Yamasaki T, Okawara T. Antiinflammation and anti-fibroblastic actions of interleukin-1 blockers. J Ocular Pharmacol Trier 1998; 14: 375-88.
12. Xiao JG, Schwade N, Chiou GCY. Mechanisms of antagonism of interleukin-1 (IL-1) by synthetic IL-1 blockers. J Ocular Pharmacol Ther 1995; 11: 369-78.
13. Schwade N, Chiou GCY. Effects of interleukin-1 blockers on ophthalmic wound healing in rabbit model of trabeculectomy. J Ocular Pharmacol Ther 1995; 11: 125-34.
14. Okawara T, Nakayama K, Furukawa M. Facile formation of l,3-disubstituted-2,3,5,6-tetrahydro-2thioxopyrimidin-4(IH)-ones and 2-N,3-disubstituted-2,3,5, 6-tetrahydro-2-imino-l, 3-thiazin-4-ones from thioureas and β-haloacyl halides. Chem Pharm Bull 1983; 31: 507-12.
15. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96: 99-113.
16. Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1914; 82: 377-90.